Background: Acute Kidney Injury (AKI) is common in neonates admitted to the Neonatal Intensive Care Unit (NICU). Neonatal AKI is associated with multiple comorbid conditions of greater clinical severity, which also increase the neonate's risk of mortality. Understanding the risk of mortality, in addition to the severity of AKI, may be useful in determining alternative treatment options for neonates with AKI.
Methods: Two independent datasets containing neonatal patient data from eleven healthcare centers were filtered, cleaned, and combined to produce a dataset fit for training and testing with seven Machine Learning algorithms. After initial modeling with 34 training features, feature elimination was utilized to isolate the most contributing features and create streamlined models. The models were fine-tuned using Bayesian search before being compared to select the most accurate and interpretable architecture.
Results: A patient cohort of 245 patients included 189 alive and 56 deceased neonates with incidence of AKI. Of the 245 patients included in this study, 73.5% were male and 26.5% were female, alongside a median age at entry of 12 h and interquartile range of 35 h. Three tree-based models, Random Forest, XGBoost, and LightGBM, were found to be the most accurate and interpretable of the seven models tested. Support Vector Machine produced similar results, albeit with less interpretability. The RAMA (Raina, Arnav, Max, Aadi) model followed results of the XGBoost algorithm, with Area under the Receiver Operating Characteristic Curve (AUC-ROC) of 0.882 ± 0.132, Accuracy of 0.878 ± 0.052, and F1 Score of 0.923 ± 0.029.
Conclusion: RAMA utilizes a tree-based decision-making algorithm, allowing it to determine the risk of mortality in neonates susceptible to AKI.
{"title":"RAMA: implementing Machine Learning to develop mortality risk prediction models for NICU patients with Acute Kidney Injury.","authors":"Arnav Vyas, Aadi Pandya, Maximilian Dawson, Taahir Shaikh, Gopal Agrawal, Sidharth Sethi, Sanjay Wazir, Rupesh Raina","doi":"10.1080/14767058.2026.2623378","DOIUrl":"https://doi.org/10.1080/14767058.2026.2623378","url":null,"abstract":"<p><strong>Background: </strong>Acute Kidney Injury (AKI) is common in neonates admitted to the Neonatal Intensive Care Unit (NICU). Neonatal AKI is associated with multiple comorbid conditions of greater clinical severity, which also increase the neonate's risk of mortality. Understanding the risk of mortality, in addition to the severity of AKI, may be useful in determining alternative treatment options for neonates with AKI.</p><p><strong>Methods: </strong>Two independent datasets containing neonatal patient data from eleven healthcare centers were filtered, cleaned, and combined to produce a dataset fit for training and testing with seven Machine Learning algorithms. After initial modeling with 34 training features, feature elimination was utilized to isolate the most contributing features and create streamlined models. The models were fine-tuned using Bayesian search before being compared to select the most accurate and interpretable architecture.</p><p><strong>Results: </strong>A patient cohort of 245 patients included 189 alive and 56 deceased neonates with incidence of AKI. Of the 245 patients included in this study, 73.5% were male and 26.5% were female, alongside a median age at entry of 12 h and interquartile range of 35 h. Three tree-based models, Random Forest, XGBoost, and LightGBM, were found to be the most accurate and interpretable of the seven models tested. Support Vector Machine produced similar results, albeit with less interpretability. The RAMA (Raina, Arnav, Max, Aadi) model followed results of the XGBoost algorithm, with Area under the Receiver Operating Characteristic Curve (AUC-ROC) of 0.882 ± 0.132, Accuracy of 0.878 ± 0.052, and F1 Score of 0.923 ± 0.029.</p><p><strong>Conclusion: </strong>RAMA utilizes a tree-based decision-making algorithm, allowing it to determine the risk of mortality in neonates susceptible to AKI.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2623378"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2025-12-17DOI: 10.1080/14767058.2025.2603781
Antonio Braga, Geraldo Duarte, Regis Kreitchmann, Gustavo Yano Callado, Joh Hama, Bianca Da Yong Kim, Gabriele Tonni, Evelyn Traina, Edward Araujo Júnior
<p><strong>Purpose: </strong>To synthesize current evidence on Oropouche virus infection during pregnancy, with particular emphasis on transmission dynamics, clinical presentation, diagnostic challenges, and emerging data on vertical transmission and adverse fetal and perinatal outcomes.</p><p><strong>Materials and methods: </strong>A narrative review of the literature was conducted to summarize available data on Oropouche virus infection in pregnancy. Searches were performed in PubMed/MEDLINE, Scopus, Web of Science, Embase, SciELO, and LILACS, complemented by official reports from the World Health Organization (WHO), Pan American Health Organization (PAHO), Centers for Disease Control and Prevention (CDC), and the Brazilian Ministry of Health. The search strategy included combinations of the following keywords: "Oropouche virus", "Oropouche fever", "pregnancy", "vertical transmission", "congenital infection", "fetal outcomes", "arbovirus", and "perinatal outcomes". Original studies, case reports, case series, reviews, surveillance reports, and clinical guidelines published in English, Portuguese, or Spanish were considered. No formal quality assessment or meta-analysis was performed, consistent with a narrative review design.</p><p><strong>Results: </strong>Oropouche virus is an emerging arboviral infection in Latin America, with a rapidly increasing number of cases reported in Brazil and neighboring countries. Transmission occurs mainly via Culicoides paraensis midges and Culex mosquitoes. Although infection is usually self-limiting, clinical manifestations frequently overlap with other arboviral diseases, complicating diagnosis. Growing evidence indicates that vertical transmission can occur, with confirmed cases associated with fetal demise and congenital anomalies, including microcephaly, ventriculomegaly, corpus callosum dysgenesis, cerebral atrophy, posterior fossa abnormalities, and arthrogryposis. Viral neurotropism and detection of viral RNA in placental and fetal tissues support a plausible teratogenic potential. Diagnostic confirmation relies on RT-PCR during the acute phase and serological testing thereafter. In pregnancy, management requires referral to high-risk obstetric care, serial fetal imaging, particularly focused on central nervous system evaluation, and multidisciplinary perinatal planning.</p><p><strong>Conclusion: </strong>Oropouche virus infection should be recognized as an emerging threat to maternal and fetal health. Accumulating evidence of vertical transmission and congenital involvement underscores the need to include Oropouche virus in the differential diagnosis of febrile illness during pregnancy in endemic areas. In the absence of specific treatment or licensed vaccines, prevention relies on vector control and personal protective measures. Strengthened surveillance systems, standardized diagnostic protocols, and prospective studies are urgently needed to clarify the magnitude of fetal risk, mechanisms of vertica
目的:综合妊娠期间Oropouche病毒感染的现有证据,特别强调传播动力学、临床表现、诊断挑战,以及关于垂直传播和不良胎儿和围产期结局的新数据。材料和方法:对有关妊娠期Oropouche病毒感染的文献进行综述。检索在PubMed/MEDLINE、Scopus、Web of Science、Embase、SciELO和LILACS中进行,并辅以世界卫生组织(WHO)、泛美卫生组织(PAHO)、疾病控制与预防中心(CDC)和巴西卫生部的官方报告。搜索策略包括以下关键词的组合:“Oropouche病毒”、“Oropouche热”、“妊娠”、“垂直传播”、“先天性感染”、“胎儿结局”、“虫媒病毒”和“围产期结局”。我们考虑了以英语、葡萄牙语或西班牙语发表的原始研究、病例报告、病例系列、综述、监测报告和临床指南。没有进行正式的质量评估或荟萃分析,符合叙述性回顾设计。结果:Oropouche病毒是拉丁美洲一种新出现的虫媒病毒感染,在巴西及其邻国报告的病例数量迅速增加。传播主要通过副库蠓和库蚊。虽然感染通常是自限性的,但临床表现经常与其他虫媒病毒性疾病重叠,使诊断复杂化。越来越多的证据表明,垂直传播可能发生,确诊病例与胎儿死亡和先天性异常有关,包括小头畸形、脑室肿大、胼胝体发育不良、脑萎缩、后窝异常和关节挛缩。病毒嗜神经性和胎盘和胎儿组织中病毒RNA的检测支持一种似是而非的致畸潜能。诊断确认依赖于急性期的RT-PCR和之后的血清学检测。在妊娠期,管理需要转诊到高危产科护理,连续胎儿成像,特别是集中在中枢神经系统评估和多学科围产期规划。结论:Oropouche病毒感染应被视为对孕产妇和胎儿健康的新威胁。垂直传播和先天性受累的证据越来越多,强调有必要在流行地区怀孕期间发热性疾病的鉴别诊断中纳入Oropouche病毒。在缺乏特定治疗方法或获得许可的疫苗的情况下,预防依赖于病媒控制和个人保护措施。迫切需要加强监测系统、标准化诊断方案和前瞻性研究,以明确胎儿风险的程度、垂直传播机制和先天暴露婴儿的长期结局。
{"title":"Oropouche virus infection in pregnancy: emerging evidence on vertical transmission and perinatal outcomes.","authors":"Antonio Braga, Geraldo Duarte, Regis Kreitchmann, Gustavo Yano Callado, Joh Hama, Bianca Da Yong Kim, Gabriele Tonni, Evelyn Traina, Edward Araujo Júnior","doi":"10.1080/14767058.2025.2603781","DOIUrl":"https://doi.org/10.1080/14767058.2025.2603781","url":null,"abstract":"<p><strong>Purpose: </strong>To synthesize current evidence on Oropouche virus infection during pregnancy, with particular emphasis on transmission dynamics, clinical presentation, diagnostic challenges, and emerging data on vertical transmission and adverse fetal and perinatal outcomes.</p><p><strong>Materials and methods: </strong>A narrative review of the literature was conducted to summarize available data on Oropouche virus infection in pregnancy. Searches were performed in PubMed/MEDLINE, Scopus, Web of Science, Embase, SciELO, and LILACS, complemented by official reports from the World Health Organization (WHO), Pan American Health Organization (PAHO), Centers for Disease Control and Prevention (CDC), and the Brazilian Ministry of Health. The search strategy included combinations of the following keywords: \"Oropouche virus\", \"Oropouche fever\", \"pregnancy\", \"vertical transmission\", \"congenital infection\", \"fetal outcomes\", \"arbovirus\", and \"perinatal outcomes\". Original studies, case reports, case series, reviews, surveillance reports, and clinical guidelines published in English, Portuguese, or Spanish were considered. No formal quality assessment or meta-analysis was performed, consistent with a narrative review design.</p><p><strong>Results: </strong>Oropouche virus is an emerging arboviral infection in Latin America, with a rapidly increasing number of cases reported in Brazil and neighboring countries. Transmission occurs mainly via Culicoides paraensis midges and Culex mosquitoes. Although infection is usually self-limiting, clinical manifestations frequently overlap with other arboviral diseases, complicating diagnosis. Growing evidence indicates that vertical transmission can occur, with confirmed cases associated with fetal demise and congenital anomalies, including microcephaly, ventriculomegaly, corpus callosum dysgenesis, cerebral atrophy, posterior fossa abnormalities, and arthrogryposis. Viral neurotropism and detection of viral RNA in placental and fetal tissues support a plausible teratogenic potential. Diagnostic confirmation relies on RT-PCR during the acute phase and serological testing thereafter. In pregnancy, management requires referral to high-risk obstetric care, serial fetal imaging, particularly focused on central nervous system evaluation, and multidisciplinary perinatal planning.</p><p><strong>Conclusion: </strong>Oropouche virus infection should be recognized as an emerging threat to maternal and fetal health. Accumulating evidence of vertical transmission and congenital involvement underscores the need to include Oropouche virus in the differential diagnosis of febrile illness during pregnancy in endemic areas. In the absence of specific treatment or licensed vaccines, prevention relies on vector control and personal protective measures. Strengthened surveillance systems, standardized diagnostic protocols, and prospective studies are urgently needed to clarify the magnitude of fetal risk, mechanisms of vertica","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2603781"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-04DOI: 10.1080/14767058.2025.2607251
Esther Namutosi, Prosper Akankwasa, Idrissa A Suleiman, Stellamaris Muthue Andrew, John Katongole, Jackson Kakooza, Catherine R Lewis, Emmanuel Okurut, Daniel Udofia Owu, Nightingale Khamonya Senaji
Objective: Labor induction is a common obstetric procedure, with success depending on accurate cervical assessment. The Bishop score, used traditionally, is subjective and limited, while transvaginal sonography (TVS) offers objective cervical length measurement. This systematic review and meta-analysis aimed to compare the accuracy of preinduction TVS and Bishop Score in predicting successful labor induction.
Methods: Following PRISMA guidelines, we searched PubMed, Scopus, Web of Science, and Lens.org for articles from January 2015 to October 2024 for observational studies comparing TVS and Bishop Score in term pregnancies (≥37 weeks). Eligible studies reported diagnostic accuracy metrics for successful vaginal delivery. Data were extracted using a standardized form, and study quality was assessed with QUADAS-2. A random-effects meta-analysis calculated pooled log odds ratios (ORs), with heterogeneity assessed via I2 and publication bias via fail-safe N, Kendall's tau, and Egger's regression. A p-value <0.05 was considered significant.
Results: Ten studies (n = 1,612 patients) were included from diverse regions (India, Iran, Türkiye). The pooled OR was 2.1726 (95% CI: 0.9493-4.9706, p = 0.0662), suggesting TVS has 2.17 times higher odds of predicting successful induction than Bishop score, though not statistically significant. TVS achieved a 60.2% success rate versus 48.7% for Bishop score (absolute difference: 11.5%). High heterogeneity (I2 = 73.12%, p < 0.001) was observed, with TVS performing better in primigravida and prostaglandin induction settings. No publication bias was detected (Fail-Safe N = 35, Egger's p = 0.944).
Conclusion: TVS shows a moderate, non-significant advantage over Bishop score in predicting successful labor induction. High heterogeneity suggests context-specific performance. Further research should explore whether a combined TVS-Bishop score approach could optimize clinical decision-making. Further research is needed to standardize protocols and assess cost-effectiveness across diverse settings.
目的:引产是一种常见的产科手术,成功与否取决于准确的宫颈评估。传统上使用的Bishop评分是主观和有限的,而经阴道超声(TVS)提供客观的宫颈长度测量。本系统回顾和荟萃分析旨在比较引产前TVS和Bishop评分预测引产成功的准确性。方法:根据PRISMA指南,我们检索PubMed、Scopus、Web of Science和Lens.org从2015年1月到2024年10月的文章,比较TVS和Bishop Score在足月妊娠(≥37周)中的观察性研究。符合条件的研究报告了成功阴道分娩的诊断准确性指标。使用标准化表格提取数据,并使用QUADAS-2评估研究质量。随机效应荟萃分析计算汇总对数比值比(or),通过I2评估异质性,通过故障安全N、Kendall’s tau和Egger’s回归评估发表偏倚。p值结果:10项研究(n = 1,612例患者)来自不同地区(印度、伊朗、土耳其)。合并OR为2.1726 (95% CI: 0.9493-4.9706, p = 0.0662),提示TVS预测成功诱导的几率比Bishop评分高2.17倍,但无统计学意义。TVS的成功率为60.2%,而Bishop的成功率为48.7%(绝对差11.5%)。异质性高(I2 = 73.12%, p N = 35, Egger’s p = 0.944)。结论:TVS在预测成功引产方面表现出适度的、不显著的优势。高异质性意味着上下文特定的性能。进一步的研究应探讨联合TVS-Bishop评分法是否可以优化临床决策。需要进一步的研究来标准化方案并评估不同环境下的成本效益。
{"title":"Accuracy of preinduction transvaginal sonography (TVS) and bishop scores in predicting successful labor induction: a global systematic review and meta-analysis.","authors":"Esther Namutosi, Prosper Akankwasa, Idrissa A Suleiman, Stellamaris Muthue Andrew, John Katongole, Jackson Kakooza, Catherine R Lewis, Emmanuel Okurut, Daniel Udofia Owu, Nightingale Khamonya Senaji","doi":"10.1080/14767058.2025.2607251","DOIUrl":"10.1080/14767058.2025.2607251","url":null,"abstract":"<p><strong>Objective: </strong>Labor induction is a common obstetric procedure, with success depending on accurate cervical assessment. The Bishop score, used traditionally, is subjective and limited, while transvaginal sonography (TVS) offers objective cervical length measurement. This systematic review and meta-analysis aimed to compare the accuracy of preinduction TVS and Bishop Score in predicting successful labor induction.</p><p><strong>Methods: </strong>Following PRISMA guidelines, we searched PubMed, Scopus, Web of Science, and Lens.org for articles from January 2015 to October 2024 for observational studies comparing TVS and Bishop Score in term pregnancies (≥37 weeks). Eligible studies reported diagnostic accuracy metrics for successful vaginal delivery. Data were extracted using a standardized form, and study quality was assessed with QUADAS-2. A random-effects meta-analysis calculated pooled log odds ratios (ORs), with heterogeneity assessed <i>via</i> I<sup>2</sup> and publication bias <i>via</i> fail-safe N, Kendall's tau, and Egger's regression. A p-value <0.05 was considered significant.</p><p><strong>Results: </strong>Ten studies (<i>n</i> = 1,612 patients) were included from diverse regions (India, Iran, Türkiye). The pooled OR was 2.1726 (95% CI: 0.9493-4.9706, <i>p</i> = 0.0662), suggesting TVS has 2.17 times higher odds of predicting successful induction than Bishop score, though not statistically significant. TVS achieved a 60.2% success rate versus 48.7% for Bishop score (absolute difference: 11.5%). High heterogeneity (I<sup>2</sup> = 73.12%, <i>p</i> < 0.001) was observed, with TVS performing better in primigravida and prostaglandin induction settings. No publication bias was detected (Fail-Safe <i>N</i> = 35, Egger's <i>p</i> = 0.944).</p><p><strong>Conclusion: </strong>TVS shows a moderate, non-significant advantage over Bishop score in predicting successful labor induction. High heterogeneity suggests context-specific performance. Further research should explore whether a combined TVS-Bishop score approach could optimize clinical decision-making. Further research is needed to standardize protocols and assess cost-effectiveness across diverse settings.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2607251"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-04DOI: 10.1080/14767058.2025.2607822
Mao Xuefeng, Zhu Hongtao
Objectives: This study aimed to investigate the independent and synergistic associations of obesity and gestational diabetes mellitus (GDM) with cesarean delivery risk, while comparing body mass index (BMI) and body roundness index (BRI) as indicators of obesity in the National Health and Nutrition Examination Survey (NHANES).
Methods: We analyzed cross-sectional data from 6292 women aged ≥20 years in NHANES 2005-2018. Cesarean delivery history and GDM status were self-reported. Obesity was defined as BMI ≥ 30 kg/m2 or BRI > 5.5. Weighted multivariable logistic regression models adjusted for demographics (age, race, education, poverty-income ratio), smoking, and alcohol use were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Restricted cubic spline and subgroup analyses evaluated nonlinear relationships and effect modifications. All analyses were performed using R 4.5.1.
Results: Overall, 47.1% reported cesarean delivery. After full adjustment, obesity (BMI-based: aOR = 1.11, 95% CI: 1.06-1.17; BRI-based: aOR = 1.10, 95% CI: 1.05-1.14) and GDM (aOR = 1.09, 95% CI: 1.03-1.16) independently increased cesarean risk. A significant synergistic effect was observed: women with both obesity and GDM had 24% higher risk (BMI-based aOR = 1.24, 95% CI: 1.15-1.34; BRI-based aOR = 1.22, 95% CI: 1.14-1.30) compared to those without either condition. Subgroup analyses revealed that the obesity-related effect was more significant only among women with GDM. BRI demonstrated greater stability than BMI, showing no interaction with smoking history.
Conclusions: Both obesity and GDM independently elevate cesarean delivery risk, with a pronounced synergistic effect when coexisting. BRI performs comparably to BMI but exhibits superior stability in risk prediction. Integrated prenatal screening for metabolic risks and targeted weight management may reduce avoidable cesarean deliveries.
{"title":"Association of cesarean delivery risk with obesity and gestational diabetes mellitus: a cross-sectional study of NHANES 2005-2018.","authors":"Mao Xuefeng, Zhu Hongtao","doi":"10.1080/14767058.2025.2607822","DOIUrl":"https://doi.org/10.1080/14767058.2025.2607822","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate the independent and synergistic associations of obesity and gestational diabetes mellitus (GDM) with cesarean delivery risk, while comparing body mass index (BMI) and body roundness index (BRI) as indicators of obesity in the National Health and Nutrition Examination Survey (NHANES).</p><p><strong>Methods: </strong>We analyzed cross-sectional data from 6292 women aged ≥20 years in NHANES 2005-2018. Cesarean delivery history and GDM status were self-reported. Obesity was defined as BMI ≥ 30 kg/m<sup>2</sup> or BRI > 5.5. Weighted multivariable logistic regression models adjusted for demographics (age, race, education, poverty-income ratio), smoking, and alcohol use were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Restricted cubic spline and subgroup analyses evaluated nonlinear relationships and effect modifications. All analyses were performed using R 4.5.1.</p><p><strong>Results: </strong>Overall, 47.1% reported cesarean delivery. After full adjustment, obesity (BMI-based: aOR = 1.11, 95% CI: 1.06-1.17; BRI-based: aOR = 1.10, 95% CI: 1.05-1.14) and GDM (aOR = 1.09, 95% CI: 1.03-1.16) independently increased cesarean risk. A significant synergistic effect was observed: women with both obesity and GDM had 24% higher risk (BMI-based aOR = 1.24, 95% CI: 1.15-1.34; BRI-based aOR = 1.22, 95% CI: 1.14-1.30) compared to those without either condition. Subgroup analyses revealed that the obesity-related effect was more significant only among women with GDM. BRI demonstrated greater stability than BMI, showing no interaction with smoking history.</p><p><strong>Conclusions: </strong>Both obesity and GDM independently elevate cesarean delivery risk, with a pronounced synergistic effect when coexisting. BRI performs comparably to BMI but exhibits superior stability in risk prediction. Integrated prenatal screening for metabolic risks and targeted weight management may reduce avoidable cesarean deliveries.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2607822"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-04DOI: 10.1080/14767058.2025.2605777
Yiling Cai, Chengrong Wu, Ying Song, Shunfang Wang, Li Sun, Hualei Cai
Background: Hysteroscopic tubal occlusion serves as an effective minimally invasive treatment, aiming to improve the efficacy of assisted reproductive technologies by preventing hydrosalpinx fluid from entering the uterine cavity. This study aims to investigate the specific alterations in the intrauterine microenvironment associated with this surgery and its positive impact on the success rate of in vitro fertilization and embryo transfer (IVF-ET).
Methods: This retrospective study included 158 patients with hydrosalpinx who underwent hysteroscopic tubal occlusion between January 2019 and December 2021. Pre- and postoperative evaluations included endometrial total protein levels, cytokines (TNF-α, bFGF, IL-10), immune markers (CD138, CD38, CD68), hormone receptors (ER, PR), uterine microbial composition, postoperative recovery, and IVF-ET pregnancy outcomes.
Results: Postoperative total protein levels in endometrial tissues significantly increased (p < 0.05). Protein levels of CD138, CD38, CD68, ER, and PR were all significantly reduced postoperatively (p < 0.05). The abundance of Lactobacillus increased significantly from 81.56% to 91.71% (χ2=4.153, p = 0.042), while other microbial species showed no significant differences. Pain scores decreased significantly from 3.24 ± 0.68 to 1.36 ± 0.31, and the mean time to return to daily activities was 1.08 ± 0.26 days. IVF-ET outcomes showed a clinical pregnancy rate of 39.87%, ongoing pregnancy rate of 32.91%, live birth rate of 29.75%, and a miscarriage rate of 6.96%, with no ectopic pregnancies reported.
Conclusions: Hysteroscopic tubal occlusion effectively alters the uterine microenviron-ment by modulating immune, hormonal, and microbial profiles, while improving patient recovery and supporting favorable pregnancy outcomes in IVF-ET.
背景:宫腔镜下输卵管闭塞术是一种有效的微创治疗方法,旨在通过防止输卵管积水进入子宫腔来提高辅助生殖技术的疗效。本研究旨在探讨与该手术相关的子宫内微环境的具体改变及其对体外受精和胚胎移植(IVF-ET)成功率的积极影响。方法:本回顾性研究包括2019年1月至2021年12月期间行宫腔镜输卵管闭塞术的158例输卵管积水患者。术前和术后评估包括子宫内膜总蛋白水平、细胞因子(TNF-α、bFGF、IL-10)、免疫标志物(CD138、CD38、CD68)、激素受体(ER、PR)、子宫微生物组成、术后恢复和IVF-ET妊娠结局。结果:术后子宫内膜组织总蛋白水平显著升高(p < 0.01),乳酸菌从81.56%升高至91.71%,差异有统计学意义(χ2=4.153, p = 0.042),其他微生物差异无统计学意义。疼痛评分从3.24±0.68降至1.36±0.31,平均恢复日常活动时间为1.08±0.26 d。IVF-ET结果显示临床妊娠率为39.87%,持续妊娠率为32.91%,活产率为29.75%,流产率为6.96%,无异位妊娠报告。结论:宫腔镜下输卵管阻塞通过调节免疫、激素和微生物谱有效改变子宫微环境,同时改善患者恢复并支持IVF-ET的良好妊娠结局。
{"title":"Impact of hysteroscopic tubal occlusion on the uterine microenvironment and pregnancy outcomes in tubal factor infertility.","authors":"Yiling Cai, Chengrong Wu, Ying Song, Shunfang Wang, Li Sun, Hualei Cai","doi":"10.1080/14767058.2025.2605777","DOIUrl":"https://doi.org/10.1080/14767058.2025.2605777","url":null,"abstract":"<p><strong>Background: </strong>Hysteroscopic tubal occlusion serves as an effective minimally invasive treatment, aiming to improve the efficacy of assisted reproductive technologies by preventing hydrosalpinx fluid from entering the uterine cavity. This study aims to investigate the specific alterations in the intrauterine microenvironment associated with this surgery and its positive impact on the success rate of <i>in vitro</i> fertilization and embryo transfer (IVF-ET).</p><p><strong>Methods: </strong>This retrospective study included 158 patients with hydrosalpinx who underwent hysteroscopic tubal occlusion between January 2019 and December 2021. Pre- and postoperative evaluations included endometrial total protein levels, cytokines (TNF-α, bFGF, IL-10), immune markers (CD138, CD38, CD68), hormone receptors (ER, PR), uterine microbial composition, postoperative recovery, and IVF-ET pregnancy outcomes.</p><p><strong>Results: </strong>Postoperative total protein levels in endometrial tissues significantly increased (<i>p</i> < 0.05). Protein levels of CD138, CD38, CD68, ER, and PR were all significantly reduced postoperatively (<i>p</i> < 0.05). The abundance of <i>Lactobacillus</i> increased significantly from 81.56% to 91.71% (χ<sup>2</sup>=4.153, <i>p</i> = 0.042), while other microbial species showed no significant differences. Pain scores decreased significantly from 3.24 ± 0.68 to 1.36 ± 0.31, and the mean time to return to daily activities was 1.08 ± 0.26 days. IVF-ET outcomes showed a clinical pregnancy rate of 39.87%, ongoing pregnancy rate of 32.91%, live birth rate of 29.75%, and a miscarriage rate of 6.96%, with no ectopic pregnancies reported.</p><p><strong>Conclusions: </strong>Hysteroscopic tubal occlusion effectively alters the uterine microenviron-ment by modulating immune, hormonal, and microbial profiles, while improving patient recovery and supporting favorable pregnancy outcomes in IVF-ET.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2605777"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To describe risk factors for declining antepartum vaccination, including the novel COVID-19 vaccine during the COVID-19 pandemic.
Methods: Retrospective cohort study including women delivering at a single center in the fall and winter of 2021. Patients without vaccine data were excluded. Baseline characteristics collected from the electronic medical record included maternal age, nulliparity, body mass index, insurance, and self-identified race/ethnicity. Those who accepted the COVID-19 vaccine were compared to those who declined. Separate comparisons were done to assess those who accepted and those who declined influenza and tetanus, diphtheria, pertussis (Tdap) vaccines as well. Statistical analysis was performed using Student's t-test, Fisher's exact test, chi square, and logistic regression. The regression model assessed the impact of patient characteristics on vaccine acceptance and was adjusted for age, nulliparity, body mass index, insurance, and race/ethnicity.
Results: Vaccine data was available for 772 patients. The rate of acceptance was 46.1% for COVID-19 vaccine, 58.0% for influenza vaccine, and 80.8% for Tdap vaccine. Those who accepted the COVID-19 vaccine were older (34.3 ± 3.8 years vs 33.0 ± 4.8 years, p < 0.001) and more frequently nulliparous (8.7% vs 2.9%, p < 0.001) than those declining it. Those accepting Tdap were also older (33.8 ± 4.3 vs 32.7 ± 4.9 years, p = 0.006). Insurance type differed across groups for all three vaccines (p < 0.001). Race differed between acceptance and refusal of the influenza and Tdap vaccines, but not the COVID-19 group. In the adjusted analysis, public insurance remained independently associated with reduced acceptance for COVID-19 (aOR 0.28, 95% CI 0.14-0.55) and influenza (aOR 0.38, 95% CI 0.20-0.73), but not for Tdap. Older age and nulliparity were independently associated with increased acceptance of COVID-19.
Conclusion: Public insurance in pregnancy is associated with a decreased likelihood of vaccine acceptance for the COVID-19 and influenza vaccines. Specific efforts for understanding the motivations for declining vaccination are needed to develop strategies to improve uptake in this population.
目的:探讨新型冠状病毒肺炎(COVID-19)大流行期间产前疫苗接种率下降的危险因素。方法:回顾性队列研究,纳入2021年秋冬在单一中心分娩的妇女。没有疫苗资料的患者被排除在外。从电子病历中收集的基线特征包括产妇年龄、未生育、体重指数、保险和自我认定的种族/民族。接受COVID-19疫苗的人与拒绝接种疫苗的人进行了比较。对接受和拒绝接种流感、破伤风、白喉、百日咳(Tdap)疫苗的人进行了单独比较。统计分析采用学生t检验、Fisher精确检验、卡方检验和逻辑回归。回归模型评估了患者特征对疫苗接受度的影响,并根据年龄、未生育、体重指数、保险和种族/民族进行了调整。结果:772例患者可获得疫苗资料。新冠肺炎疫苗、流感疫苗和百白破疫苗的合格率分别为46.1%、58.0%和80.8%。接种新冠肺炎疫苗组年龄较大(34.3±3.8岁vs 33.0±4.8岁,p p p = 0.006)。所有三种疫苗的保险类型在各组之间存在差异(p结论:妊娠期公共保险与COVID-19和流感疫苗接受可能性降低有关。需要做出具体努力,了解疫苗接种率下降的动机,以制定策略,提高这一人群的接种率。
{"title":"Vaccine acceptance in gravid patients in the COVID-19 era.","authors":"Stephanie Schreiber-Gonzalez, Karlie Snead, Alexandra Jd Phelps, Dorothy Hakimian, Rachel Harrison, Calla Holmgren","doi":"10.1080/14767058.2026.2612841","DOIUrl":"https://doi.org/10.1080/14767058.2026.2612841","url":null,"abstract":"<p><strong>Objective: </strong>To describe risk factors for declining antepartum vaccination, including the novel COVID-19 vaccine during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Retrospective cohort study including women delivering at a single center in the fall and winter of 2021. Patients without vaccine data were excluded. Baseline characteristics collected from the electronic medical record included maternal age, nulliparity, body mass index, insurance, and self-identified race/ethnicity. Those who accepted the COVID-19 vaccine were compared to those who declined. Separate comparisons were done to assess those who accepted and those who declined influenza and tetanus, diphtheria, pertussis (Tdap) vaccines as well. Statistical analysis was performed using Student's t-test, Fisher's exact test, chi square, and logistic regression. The regression model assessed the impact of patient characteristics on vaccine acceptance and was adjusted for age, nulliparity, body mass index, insurance, and race/ethnicity.</p><p><strong>Results: </strong>Vaccine data was available for 772 patients. The rate of acceptance was 46.1% for COVID-19 vaccine, 58.0% for influenza vaccine, and 80.8% for Tdap vaccine. Those who accepted the COVID-19 vaccine were older (34.3 ± 3.8 years vs 33.0 ± 4.8 years, <i>p</i> < 0.001) and more frequently nulliparous (8.7% vs 2.9%, <i>p</i> < 0.001) than those declining it. Those accepting Tdap were also older (33.8 ± 4.3 vs 32.7 ± 4.9 years, <i>p</i> = 0.006). Insurance type differed across groups for all three vaccines (<i>p</i> < 0.001). Race differed between acceptance and refusal of the influenza and Tdap vaccines, but not the COVID-19 group. In the adjusted analysis, public insurance remained independently associated with reduced acceptance for COVID-19 (aOR 0.28, 95% CI 0.14-0.55) and influenza (aOR 0.38, 95% CI 0.20-0.73), but not for Tdap. Older age and nulliparity were independently associated with increased acceptance of COVID-19.</p><p><strong>Conclusion: </strong>Public insurance in pregnancy is associated with a decreased likelihood of vaccine acceptance for the COVID-19 and influenza vaccines. Specific efforts for understanding the motivations for declining vaccination are needed to develop strategies to improve uptake in this population.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2612841"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-01Epub Date: 2026-01-15DOI: 10.1080/14767058.2026.2614836
Supakit Mhernchan, Vorapong Phupong
Objective: To determine the predictive value of serum IGFBP-3 in combination with transvaginal ultrasonography cervical length in singleton pregnancies during the 18-23+6 weeks' gestational period for the prediction of preterm birth.
Methods: This prospective observational study included singleton pregnant women who received antenatal care at King Chulalongkorn Memorial Hospital at 18-23+6 weeks' gestation between December 2022 and April 2024. Cervical length was determined by transvaginal ultrasound and serum was collected to measure IGFBP-3 levels. Demographic data and pregnancy outcomes were recorded.
Results: A total of 176 pregnant women were analyzed. Twelve cases (6.8%) of preterm births were identified. Preterm birth prediction, when using serum IGFBP-3 values greater than 6.9 ng/ml, had a sensitivity of 75%, a specificity of 61.5%, a positive predictive value (PPV) of 12.3% and a negative predictive value (NPV) of 97.1%. When cervical length values less than 37 mm were used, the prediction had a sensitivity of 66.7%, a specificity of 44.6%, a PPV of 8%, and a NPV of 94.9%. When serum IGFBP-3 or cervical length was used to predict preterm birth, sensitivity, specificity, PPV and NPV were 83.3%, 27.1%, 7.6% and 95.7%, respectively.
Conclusions: The use of serum IGFBP-3 levels in combination with cervical length had a good sensitivity to predict preterm birth. While NPV is high, the low PPV limits its standalone use to predict preterm birth.
{"title":"Predictive value of serum IGFBP-3 and transvaginal cervical length measurement for spontaneous preterm birth in singleton pregnancies: a prospective study.","authors":"Supakit Mhernchan, Vorapong Phupong","doi":"10.1080/14767058.2026.2614836","DOIUrl":"10.1080/14767058.2026.2614836","url":null,"abstract":"<p><strong>Objective: </strong>To determine the predictive value of serum IGFBP-3 in combination with transvaginal ultrasonography cervical length in singleton pregnancies during the 18-23<sup>+6</sup> weeks' gestational period for the prediction of preterm birth.</p><p><strong>Methods: </strong>This prospective observational study included singleton pregnant women who received antenatal care at King Chulalongkorn Memorial Hospital at 18-23<sup>+6</sup> weeks' gestation between December 2022 and April 2024. Cervical length was determined by transvaginal ultrasound and serum was collected to measure IGFBP-3 levels. Demographic data and pregnancy outcomes were recorded.</p><p><strong>Results: </strong>A total of 176 pregnant women were analyzed. Twelve cases (6.8%) of preterm births were identified. Preterm birth prediction, when using serum IGFBP-3 values greater than 6.9 ng/ml, had a sensitivity of 75%, a specificity of 61.5%, a positive predictive value (PPV) of 12.3% and a negative predictive value (NPV) of 97.1%. When cervical length values less than 37 mm were used, the prediction had a sensitivity of 66.7%, a specificity of 44.6%, a PPV of 8%, and a NPV of 94.9%. When serum IGFBP-3 or cervical length was used to predict preterm birth, sensitivity, specificity, PPV and NPV were 83.3%, 27.1%, 7.6% and 95.7%, respectively.</p><p><strong>Conclusions: </strong>The use of serum IGFBP-3 levels in combination with cervical length had a good sensitivity to predict preterm birth. While NPV is high, the low PPV limits its standalone use to predict preterm birth.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2614836"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: The aim of this study was to compare the time to delivery between early (within 2 h) and late (after 2 h) amniotomy and oxytocin initiation in patients undergoing cervical ripening with a cervical ripening balloon (CRB).
Methods: Secondary analysis of data collected from a previous parallel randomized controlled trial comparing CRB removal after 6 versus 12 h. For our study, the full cohort from the original trial was divided into patients who had amniotomy and oxytocin infusion within 2 h of CRB removal (study group) and patients who hadamniotomy and oxytocin more than 2 h after CRB removal (control group). Inclusion criteria were age > 18 years, ≥ 37 gestational weeks, Bishop score < 5, singleton vertex presentation, intact membranes, and no contraindication for vaginal delivery. Primary outcome for the current study was the time from CRB removal to delivery. Secondary outcomes included the rate of cesarean delivery and adverse maternal and neonatal outcomes.
Results: A total of 197 patients were analyzed, 34 in the study group and 163 in the control group. The study and control groups did not differ in baseline characteristics but differences were observed in the treatment characteristics stemming from the division into the two groups for the analysis. Time from CRB removal to delivery was significantly shorter in the study group vs control (9 ± 6.7 vs.17 ± 11.9 h, p < 0.001) respectively. The rate of cesarean deliveries and other maternal and neonatal outcomes were similar in the two groups.
Conclusion: Our findings suggest that early amniotomy and oxytocin infusion combination in patients undergoing labor induction with a CRB is associated with a shorter duration of labor and similar cesarean deliveries rate. Latent confounding remains possible.
目的:本研究的目的是比较早(2小时内)和晚(2小时后)羊膜切开术和催产素启动宫颈成熟(CRB)患者的分娩时间。方法:从先前的一项平行随机对照试验中收集的数据进行二次分析,比较6 h和12 h后CRB的去除情况。在我们的研究中,原始试验的全部队列被分为在CRB移除后2小时内进行羊膜切开和催产素输注的患者(研究组)和在CRB移除后2小时以上进行羊膜切开和催产素输注的患者(对照组)。纳入标准为年龄bb0 ~ 18岁,≥37孕周,Bishop评分< 5,单胎顶点呈现,膜完整,无阴道分娩禁忌。本研究的主要结果是从CRB移除到交付的时间。次要结局包括剖宫产率、孕产妇和新生儿不良结局。结果:共分析197例患者,其中研究组34例,对照组163例。研究组和对照组在基线特征上没有差异,但在治疗特征上观察到差异,这源于两组的分析。研究组从CRB取出到分娩的时间明显短于对照组(9±6.7 h vs.17±11.9 h)。结论:我们的研究结果表明,早期羊膜切开联合催产素输注合并CRB引产患者的分娩时间较短,剖宫产率相近。潜在的混淆仍然是可能的。
{"title":"Early versus late combined amniotomy and oxytocin after mechanical cervical ripening-a secondary analysis of a randomized controlled trial.","authors":"Joanna Dakwar Shaheen, Sharon Einav, Rami Sammour, Shlomi Sagi, Inna Bleicher","doi":"10.1080/14767058.2025.2610572","DOIUrl":"10.1080/14767058.2025.2610572","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to compare the time to delivery between early (within 2 h) and late (after 2 h) amniotomy and oxytocin initiation in patients undergoing cervical ripening with a cervical ripening balloon (CRB).</p><p><strong>Methods: </strong>Secondary analysis of data collected from a previous parallel randomized controlled trial comparing CRB removal after 6 versus 12 h. For our study, the full cohort from the original trial was divided into patients who had amniotomy and oxytocin infusion within 2 h of CRB removal (study group) and patients who hadamniotomy and oxytocin more than 2 h after CRB removal (control group). Inclusion criteria were age > 18 years, ≥ 37 gestational weeks, Bishop score < 5, singleton vertex presentation, intact membranes, and no contraindication for vaginal delivery. Primary outcome for the current study was the time from CRB removal to delivery. Secondary outcomes included the rate of cesarean delivery and adverse maternal and neonatal outcomes.</p><p><strong>Results: </strong>A total of 197 patients were analyzed, 34 in the study group and 163 in the control group. The study and control groups did not differ in baseline characteristics but differences were observed in the treatment characteristics stemming from the division into the two groups for the analysis. Time from CRB removal to delivery was significantly shorter in the study group vs control (9 ± 6.7 vs.17 ± 11.9 h, <i>p</i> < 0.001) respectively. The rate of cesarean deliveries and other maternal and neonatal outcomes were similar in the two groups.</p><p><strong>Conclusion: </strong>Our findings suggest that early amniotomy and oxytocin infusion combination in patients undergoing labor induction with a CRB is associated with a shorter duration of labor and similar cesarean deliveries rate. Latent confounding remains possible.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2610572"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Early-onset hypoglycemia is a frequent metabolic complication in preterm infants and may lead to adverse neurodevelopmental outcomes. Accurate risk prediction is essential for timely clinical intervention.
Methods: A retrospective study was conducted on 436 preterm infants admitted to a tertiary hospital in Guangzhou from January 2022 to November 2023. The dataset was randomly divided into a training set (n = 305) and a validation set (n = 131). Univariate analysis and LASSO logistic regression were used to screen predictive variables. A multivariate logistic regression model was developed and visualized as a nomogram. Internal validation was performed using calibration plots, ROC curves, and decision curve analysis (DCA).
Results: A retrospective cohort of 436 preterm infants was analyzed, among whom 124 cases (28.44%) experienced hypoglycemia within 48 h after birth. Multivariate logistic regression identified six independent risk factors: reduced gestational age, multiple births, cesarean delivery, maternal gestational diabetes, gestational hypertension, and abdominal distension observed on the second postnatal day. The predictive model exhibited solid discriminative power, with an AUC of 0.802 in the training group and 0.829 in the validation group. Model calibration was satisfactory across datasets. DCA further supported the model's clinical utility, indicating consistent net benefit over a wide spectrum of risk thresholds.
Conclusion: The model demonstrated promising predictive ability for early-onset hypoglycemia in preterm infants and could potentially serve as a preliminary tool to inform risk stratification strategies. However, its clinical translation requires confirmation through external validation in prospective, multicenter studies before any consideration of widespread implementation.
{"title":"Development and validation of a risk prediction model for early-onset hypoglycemia in preterm infants.","authors":"Rongdan Li, Chunmei He, Mei Luo, Miaoqiong Situ, Zhiying Li, Qiaoqing Xie","doi":"10.1080/14767058.2026.2620827","DOIUrl":"https://doi.org/10.1080/14767058.2026.2620827","url":null,"abstract":"<p><strong>Background: </strong>Early-onset hypoglycemia is a frequent metabolic complication in preterm infants and may lead to adverse neurodevelopmental outcomes. Accurate risk prediction is essential for timely clinical intervention.</p><p><strong>Methods: </strong>A retrospective study was conducted on 436 preterm infants admitted to a tertiary hospital in Guangzhou from January 2022 to November 2023. The dataset was randomly divided into a training set (<i>n</i> = 305) and a validation set (<i>n</i> = 131). Univariate analysis and LASSO logistic regression were used to screen predictive variables. A multivariate logistic regression model was developed and visualized as a nomogram. Internal validation was performed using calibration plots, ROC curves, and decision curve analysis (DCA).</p><p><strong>Results: </strong>A retrospective cohort of 436 preterm infants was analyzed, among whom 124 cases (28.44%) experienced hypoglycemia within 48 h after birth. Multivariate logistic regression identified six independent risk factors: reduced gestational age, multiple births, cesarean delivery, maternal gestational diabetes, gestational hypertension, and abdominal distension observed on the second postnatal day. The predictive model exhibited solid discriminative power, with an AUC of 0.802 in the training group and 0.829 in the validation group. Model calibration was satisfactory across datasets. DCA further supported the model's clinical utility, indicating consistent net benefit over a wide spectrum of risk thresholds.</p><p><strong>Conclusion: </strong>The model demonstrated promising predictive ability for early-onset hypoglycemia in preterm infants and could potentially serve as a preliminary tool to inform risk stratification strategies. However, its clinical translation requires confirmation through external validation in prospective, multicenter studies before any consideration of widespread implementation.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2620827"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146087815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Listeria monocytogenes is a pathogenic Gram-positive bacterium that poses a serious threat to pregnant women and their fetuses. This case report aims to highlight the management and outcomes of such an infection in a pregnancy with multiple complications.
Methods: We describe the clinical management of a 33-year-old woman who conceived via in vitro fertilization (IVF) and presented in the third trimester with Listeria monocytogenes infection, complicated by complete placenta previa, a succenturiate placenta, and breech presentation.
Results: Despite prompt medical intervention, intrauterine fetal demise occurred. Following prophylactic uterine artery embolization (UAE), successful vaginal delivery was achieved. Three months postpartum, her menstrual cycle returned to normal. After monitoring her follicles during natural cycles, she successfully conceived again within one cycle, experienced a smooth pregnancy, and ultimately delivered a healthy baby boy at term.
Conclusions: This case underscores the importance of increased awareness regarding the risk of Listeria monocytogenes infection during pregnancy. It discusses the potential of applying next-generation sequencing (NGS) to amniotic fluid samples obtained via amniocentesis for early diagnosis and highlights that performing uterine artery embolization when necessary can help maximize the preservation of fertility.
{"title":"Clinical management of late-stage <i>Listeria monocytogenes</i> infection with complete placenta previa: a case report of conception in a natural cycle following stillbirth.","authors":"Tingting Wu, Lifang Ren, Limei Bian, Chunzhu Liu, Huijuan Tao, Ruijuan Cui","doi":"10.1080/14767058.2026.2620259","DOIUrl":"10.1080/14767058.2026.2620259","url":null,"abstract":"<p><strong>Objective: </strong><i>Listeria monocytogenes</i> is a pathogenic Gram-positive bacterium that poses a serious threat to pregnant women and their fetuses. This case report aims to highlight the management and outcomes of such an infection in a pregnancy with multiple complications.</p><p><strong>Methods: </strong>We describe the clinical management of a 33-year-old woman who conceived via in vitro fertilization (IVF) and presented in the third trimester with <i>Listeria monocytogenes</i> infection, complicated by complete placenta previa, a succenturiate placenta, and breech presentation.</p><p><strong>Results: </strong>Despite prompt medical intervention, intrauterine fetal demise occurred. Following prophylactic uterine artery embolization (UAE), successful vaginal delivery was achieved. Three months postpartum, her menstrual cycle returned to normal. After monitoring her follicles during natural cycles, she successfully conceived again within one cycle, experienced a smooth pregnancy, and ultimately delivered a healthy baby boy at term.</p><p><strong>Conclusions: </strong>This case underscores the importance of increased awareness regarding the risk of <i>Listeria monocytogenes</i> infection during pregnancy. It discusses the potential of applying next-generation sequencing (NGS) to amniotic fluid samples obtained via amniocentesis for early diagnosis and highlights that performing uterine artery embolization when necessary can help maximize the preservation of fertility.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"39 1","pages":"2620259"},"PeriodicalIF":1.6,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146068493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}